ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Verona announces positive results for DPI form of COPD drug pharmaceutical-technology
August 06, 2019UK-based Verona Pharma have announced the dry powdered inhaler (DPI) formulation of ensifentrine for chronic obstructive pulmonary disorder (COPD) has achieved all the endpoints in a Phase II trial. -
NICE approves AstraZeneca’s COPD drug
europeanpharmaceuticalreview
July 04, 2017The National Institute for Health and Care Excellence (NICE) has published draft guidance recommending roflumilast (Daxas, AstraZeneca) for chronic obstructive pulmonary disease (COPD).
Pharma Sources Insight July 2025
